Luciano Costa/LinkedIn
May 26, 2025, 08:09
Luciano Costa: JNJ-5322 is Likely The Greatest Innovation We Have Seen in a Few Years
Luciano J Costa, Professor at University of Alabama at Birmingham, shared a post on X:
“A lot in multiple myeloma at ASCO.
JNJ-5322 is likely the greatest innovation we have seen in a few years.
Potential to disrupt our approach to immunotherapy even before we figure out the current players.
Congratulations to the investigators.”
More posts featuring ASCO25.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 8, 2025, 17:03
Jun 8, 2025, 16:53